ArticleMolecular & cellular proteomics : MCP2026
The Activation of ARF1 Is Dynamically Regulated by its Palmitoylation.
Article in Molecular & cellular proteomics : MCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ARF1 plays a crucial role in maintaining the structure and function of the Golgi apparatus, yet the precise on-site regulatory mechanism governing ARF1 activation remains incompletely understood. Here, we have uncovered a novel regulatory mechanism involving the palmitoylation of ARF1 at Cys159. Our findings in HEK293T cells demonstrate that ZDHHC8 is responsible for promoting ARF1 palmitoylation, while PPT2 is involved in the depalmitoylation of ARF1. Furthermore, our results indicate that mutation of Cys159 to Alanine abolishes ARF1 palmitoylation, leading to increased localization of ARF1 at the Golgi apparatus. Interestingly, we observed that upregulation of ARF1 palmitoylation by ZDHHC8 inhibits ARF1 activation, while downregulation of ARF1 palmitoylation through the expression of PPT2 or Cys159 to Alanine enhances ARF1 activation. Mechanistically, we propose that ARF1 palmitoylation plays a crucial role in regulating retrograde transport by interacting with key proteins such as β-COP and β-actin. Our study presents a model in which the activation of ARF1 is dynamically regulated by its palmitoylation status, shedding light on a previously unrecognized mechanism for controlling ARF1 function at the Golgi apparatus. These findings provide valuable insights into the regulatory pathways governing intracellular protein transport and cellular function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.